As you may already be aware, in November 2022, the Office of the US Trade Representative (USTR) announced that it would extend Section 301 tariff exclusions on medical products used to treat COVID-19 for an additional 90 days.

With the exclusions set to expire on February 28th, the USTR announced they are seeking public comments on whether to extend the exclusions further.

The USTR is requesting public comments to determine whether they should extend the exclusions for up to another six months. To allow for comments, an interim 75-day extension was granted for the exclusions, extending the current expiration date to May 15th.

Click here to view the notice in its entirety.

Shapiro will continue to monitor the situation and provide updates as they become available.